AGP Executive Report
Last update: 4 hours agoU.S. Cannabis Rules: The DEA’s new medical-marijuana registrations do not allow interstate sales, and the agency has rejected applications in at least six states and Washington, D.C. Hemp Products: Federal changes taking effect Dec. 11 could strip hemp status from products exceeding the new THC limit, potentially reshaping the market for hemp-derived gummies. Global CBD Markets: MediPharm Labs has launched an ANVISA-authorized cannabis extract oil in Brazil, expanding its business in a major international market. Patient Access: A freeze on South Africa’s Section 21 cannabis approvals is raising concerns about access for vulnerable patients.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.